Complete fourth quarter and full-year 2025 financial results will be announced on Thursday, February 26, 2026
Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast...
3 of Wall Street’s Favorite Stocks That Concern Us
1 Healthcare Stock to Research Further and 2 That Underwhelm
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Â
Masimo (MASI) Stock Is Up, What You Need To Know
Announces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution
1 Volatile Stock to Target This Week and 2 We Ignore
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know